ClearPoint Neuro, Inc. (CLPT) income statement
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)
Close on Nov 18, 2026Market cap $247.14MP/E –Yield –
ClearPoint Neuro, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 61.4%
- Operating margin
- -70.6%
- Net margin
- -79.4%
- Return on equity, FY2025
- -95.6%
Financial strength
- Current ratio
- 6.76
- Debt to equity
- 1.86
- Debt to assets
- 45.1%
- Cash to current liabilities
- 468.0%
Valuation
- P/E ratio
- –
- Price to sales
- 5.43
- Price to book
- 9.06
- Dividend yield
- –
See a number that looks wrong?